173154-03-5

Basic information

• Product Name: 2(3H)-Furanone, 5-[(1S,3S)-1-azido-3-(hydroxymethyl)-4-methylpentyl]dihydro-3-(1-methylethyl)-, (3S,5S)-
• Synonyms: 2(3H)-Furanone, 5-[(1S,3S)-1-azido-3-(hydroxymethyl)-4-methylpentyl]dihydro-3-(1-methylethyl)-, (3S,5S)-;(3S,5S)-5-((1S,3S)-1-azido-3-(hydroxymethyl)-4-methylpentyl)-3-isopropyldihydrofuran-2(3H)-one;173154-03-05
• CAS NO: 173154-03-5
• Molecular Formula: C14H25N3O3
• Molecular Weight: 283.37
• Product Categories: API intermediates
• Mol File: 173154-03-5.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 2(3H)-Furanone, 5-[(1S,3S)-1-azido-3-(hydroxymethyl)-4-methylpentyl]dihydro-3-(1-methylethyl)-, (3S,5S)-(CAS DataBase Reference)
• NIST Chemistry Reference: 2(3H)-Furanone, 5-[(1S,3S)-1-azido-3-(hydroxymethyl)-4-methylpentyl]dihydro-3-(1-methylethyl)-, (3S,5S)-(173154-03-5)
• EPA Substance Registry System: 2(3H)-Furanone, 5-[(1S,3S)-1-azido-3-(hydroxymethyl)-4-methylpentyl]dihydro-3-(1-methylethyl)-, (3S,5S)-(173154-03-5)

Safety Data

• Hazardous Substances Data: 173154-03-5(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
2(3H)-Furanone, 5-[(1S,3S)-1-azido-3-(hydroxymethyl)-4-methylpentyl]dihydro-3-(1-methylethyl)-, (3S,5S)is used as a potential pharmaceutical compound for its unique structure and functional groups. The presence of the azide group and hydroxymethyl group may allow for the development of new drugs with specific therapeutic properties.
Used in Materials Science:
In the field of materials science, 2(3H)-Furanone, 5-[(1S,3S)-1-azido-3-(hydroxymethyl)-4-methylpentyl]dihydro-3-(1-methylethyl)-, (3S,5S)may be utilized for the development of novel materials with specific properties. Its unique structure and functional groups could contribute to the creation of new materials with applications in various industries.
Used as a Synthetic Intermediate:
2(3H)-Furanone, 5-[(1S,3S)-1-azido-3-(hydroxymethyl)-4-methylpentyl]dihydro-3-(1-methylethyl)-, (3S,5S)can be used as a synthetic intermediate for the synthesis of other complex organic compounds. Its unique structure and functional groups may facilitate the development of new synthetic routes and the production of valuable compounds in the field of organic chemistry.

InChI:InChI=1/C14H25N3O3/c1-8(2)10(7-18)5-12(16-17-15)13-6-11(9(3)4)14(19)20-13/h8-13,18H,5-7H2,1-4H3/t10-,11+,12+,13+/m1/s1

Upstream product

• 173153-98-5 (2S,2'S,2S,4S)-2-[2-azido-2'-(4-isopropyl-5-oxo-tetrahydrofuran-2-yl)-ethyl]-3-methylbutyric acid 
• 124-41-4 sodium methylate 
• 173154-01-3 (S)-3-((2S,4S)-4-azido-2-isopropyl-4-((2S,4S)-4-isopropyl-5-oxotetrahydrofuran-2-yl)butanoyl)-4-benzyloxazolidin-2-one 

Downstream Products

• 173154-02-4 (2S,4S)-4-azido-2-isopropyl-4-[(2S,4S)-4-isopropyl-5-oxotetrahydrofuran-2-yl]butanal 
• 1257529-92-2 (3S,5S)-5-((1S,3S)-1-Azido-3-(hydroxy(4-methoxy-3-(3-methoxypropoxy)phenyl)methyl)-4-methylpentyl)-3-isopropyldihydrofuran-2(3H)-one 

Relevant articles and documents

A new synthetic route towards aliskiren intermediates

The synthesis of aliskiren intermediates was accomplished by attaching the 3,4-dialkoxyphenyl unit to precursor C-8 lactone-carboxylic acid derivatives using organometallic reagents. Totally different reactivities of the lactone-carboxylic acid chloride substrate towards organomagnesium and organoboron reagents were observed.

METHODS OF TREATING ALZHEIMER’S DISEASE USING AROMATICALLY SUBSTITUTED ω-AMINO-ALKANOIC ACID AMIDES AND ALKANOIC ACID DIAMIDES

Disclosed.are methods for treating Alzheimer's disease, and other diseases, and/or inhibiting beta-secretase enzyme, and/or inhibiting deposition of A beta peptide in a mammal, by use of compounds of formula (I) wherein the variables R1, R2, R3, R4, R5, X1, and X2 are defined herein.